Physician profile
Phillip L Thomas
NPI 1437500261
$46,103.83
in general payments reported to CMS, 2019-2025
10 companies · $4,093 in 2025
The $4,093 reported for 2025 was more than what 80% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $319 · 2020: $145 · 2021: $4,141 · 2022: $30K · 2023: $3,602 · 2024: $3,369 · 2025: $4,093.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,697 · Travel and Lodging: $4,717 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $650.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,696.53 |
| Travel and Lodging | $4,716.91 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $650.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $24,688.97 | 2022-2025 | |
| Smith+Nephew, INC. | $7,485.07 | 2021-2025 | Spatial Frame, Q-Fix, Fast-Fix |
| Foundation Medical, LLC | $6,155.99 | 2022-2025 | |
| Gemini Medical LLC | $3,600.00 | 2021-2022 | |
| Stryker Corporation | $2,894.64 | 2019-2025 | Mako, Insignia, Triathlon |
| Vericel Corporation | $672.39 | 2024-2025 | Maci |
| Medical Device Business Services, INC. | $448.80 | 2019-2022 | |
| Depuy Synthes Sales INC. | $117.18 | 2022-2024 | Mitek Cruciate+, Twistr, Truespan Orthocord |
| Convatec INC. | $20.89 | 2021 | |
| Zimmer Biomet Holdings, INC. | $19.90 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phillip Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.